|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 26, 2018 ) This 'Epigenetics Market' report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
North America is expected to dominate the epigenetics market followed by Europe. Factors such as, upsurge in epigenetics research activities, favorable government funding initiatives, great R&D expenditure, increasing occurrence of various diseases, and the presence of key players in the region can be the key factors which are likely to boost the epigenetics market in the region. However, Asia-Pacific is anticipated to possess high market potential for the growth of epigenetics market during the forecast period, owing to growing incidence of cancer and rise in healthcare expenditure. The region also expected to experience rapid market growth due to economic development.
Get Sample Pages at http://bit.ly/2Rm2mbN
Epigenetics is the study of genetic changes in gene without the involvement of changes to the underlying DNA sequence. Epigenetic change is a regular and natural occurrence but can also be influenced by several factors including age, the environment/lifestyle, and disease state.
Deteriorating sequencing costs & time, growing research activities, availability of government funding, and increasing cancer prevalence are the major drivers which are likely to anticipate the growth of epigenetics market. Increasing applications of epigenetics in personalized medicine & targeted therapy and use of epigenetics in non-oncology applications is likely to add new opportunities for this market in the coming years.
The epigenetics market is segmented based on product as reagents, kits, enzymes, instruments & consumables, and bioinformatics tools. The market by technology is categorized into histone modification, DNA methylation, and other technologies. Based on the application, the market can be segmented as metabolic diseases, oncology, cardiovascular diseases, developmental biology, and other applications. The epigenetics market based on the end-user is segmented as, academic & research institutes, contract research organizations, and pharmaceutical & biotechnology companies.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key epigenetics manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.
Some of the notable players operating the market are Merck KGaA, Thermo Fisher Scientific, Inc., Abcam plc, Agilent Technologies, Active Motif, Qiagen, Bio-Rad Laboratories, Inc., PerkinElmer Inc., New England Biolabs (NEB), and Illumina, Inc. among others.
Continuous innovation in the Epigenetics technology is a major strategy adopted by industry participants to gain significant market share.
Check Discount Here : http://bit.ly/2Rhjf75
The Insight Partners
Sameer Joshi
+1-646-491-9876
sam@theinsightpartners.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
